{"id":"d10d5339-3345-5be7-b222-fe02e3ec5677","stable_key":"44eaeae5-557a-552b-8998-884f30462e2a:sulforaphane-diabetes-hba1c","predicate":"reduced","statement":"HbA1c decreased in the reported obese dysregulated-diabetes subgroup.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"d3a87bdd-333d-550c-9999-e42f0bab5542","mechanism_event_label":"A longer-term glucose marker also changed in that subgroup.","subject":{"id":"2586cbe4-fa07-5be1-8a37-8e48b3835c42","slug":"broccoli-sprout-preparation","display_name":"Broccoli sprout preparation, composition specified per study","entity_type_key":"chemical_species"},"object":{"id":"5deaa98d-e81e-521d-b810-a9228333e4ca","slug":"glycated-hemoglobin-concentration","display_name":"Glycated hemoglobin / HbA1c concentration","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"d3a87bdd-333d-550c-9999-e42f0bab5542","stable_key":"44eaeae5-557a-552b-8998-884f30462e2a:sulforaphane-diabetes-hba1c-event","event_type":"biochemical_relationship","label":"A longer-term glucose marker also changed in that subgroup.","description":"HbA1c decreased in the reported obese dysregulated-diabetes subgroup.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"67e70215-70c4-546a-84b4-0819fac0b326","slug":"sulforaphane","display_name":"Sulforaphane / SFN, stereochemistry specified per study","entity_type_key":"small_molecule"},"role":"bioactive_component","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"2586cbe4-fa07-5be1-8a37-8e48b3835c42","slug":"broccoli-sprout-preparation","display_name":"Broccoli sprout preparation, composition specified per study","entity_type_key":"chemical_species"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"5deaa98d-e81e-521d-b810-a9228333e4ca","slug":"glycated-hemoglobin-concentration","display_name":"Glycated hemoglobin / HbA1c concentration","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/sulforaphane-research/28615356.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e\", \"start_char\": 0, \"end_char\": 1106, \"text_sha256\": \"65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Network-guided preclinical work with a human intervention","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Concentrated broccoli sprout extract; obese dysregulated-diabetes subgroup","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Model-based mechanism and clinical subgroup outcomes are distinct; no equivalence to metformin in patients is claimed.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Sulforaphane research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"sulforaphane","display_name":"Sulforaphane / SFN, stereochemistry specified per study","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Hepatic cell/animal models and humans with type 2 diabetes","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"A longer-term glucose marker also changed in that subgroup.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[sulforaphane-p28615356] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. (2017). https://pubmed.ncbi.nlm.nih.gov/28615356/ DOI: 10.1126/scitranslmed.aah4477","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Glucose production and clinical glucose control","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"bfb17561-1589-5258-bc3f-4afe8c58fa8a","evidence_kind":"source_excerpt","locator":"Lines 1165-1176","start_line":1165,"end_line":1176,"excerpt":"### sulforaphane-diabetes-hba1c\nHbA1c decreased in the reported obese dysregulated-diabetes subgroup.\nCondition category: normal\nnutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: A longer-term glucose marker also changed in that subgroup.\norganism: Hepatic cell/animal models and humans with type 2 diabetes\ntissue_or_cell_type: Glucose production and clinical glucose control\nexperimental_model: Network-guided preclinical work with a human intervention\nlimitations: Model-based mechanism and clinical subgroup outcomes are distinct; no equivalence to metformin in patients is claimed.\nexposure: Concentrated broccoli sprout extract; obese dysregulated-diabetes subgroup\nevidence_span: {\"source_cache\": \"artifacts/sulforaphane-research/28615356.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e\", \"start_char\": 0, \"end_char\": 1106, \"text_sha256\": \"65f64f5fa5e84a03d3ba4b647ce94a815fd3bd345486b726e7a54f1a813cab0e\"}\n[sulforaphane-p28615356] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. (2017). https://pubmed.ncbi.nlm.nih.gov/28615356/ DOI: 10.1126/scitranslmed.aah4477","model_system":"Network-guided preclinical work with a human intervention","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [sulforaphane-p28615356] Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. (2017). https://pubmed.ncbi.nlm.nih.gov/28615356/ DOI: 10.1126/scitranslmed.aah4477","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"a4bafbf7-f117-53c9-a6d7-8fb25e4aca72","stable_key":"import-44eaeae5-557a-552b-8998-884f30462e2a","title":"Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"f355c492a6c35673d8260b1328667fe206e5315b9fcaa5aeff53d80373c7ef97","revision_id":"f2c47d71-34cd-5160-8e92-fe196b576707","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}